Stay updated on Kadcyla Plus Pertuzumab vs. Herceptin Plus Pertuzumab Clinical Trial
Sign up to get notified when there's something new on the Kadcyla Plus Pertuzumab vs. Herceptin Plus Pertuzumab Clinical Trial page.

Latest updates to the Kadcyla Plus Pertuzumab vs. Herceptin Plus Pertuzumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in July 2025, allowing API users to provide input beforehand. Additionally, the revision number has been updated from v2.15.2 to v2.16.4.SummaryDifference0.5%
- Check65 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check72 days agoChange DetectedThe page has been updated to include new drug information related to breast cancer treatments, specifically listing several drugs such as Paclitaxel, Epirubicin, and Doxorubicin, while significant details about a previous study on trastuzumab emtansine have been removed.SummaryDifference12%
- Check86 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check94 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check130 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.5%
Stay in the know with updates to Kadcyla Plus Pertuzumab vs. Herceptin Plus Pertuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Kadcyla Plus Pertuzumab vs. Herceptin Plus Pertuzumab Clinical Trial page.